These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 7033784)

  • 21. [A new point of attack for the treatment of hypertension; captopril, an orally active inhibitor of the enzymatic conversion of angiotensin I into angiotensin II].
    Schalekamp MA; de Bruyn JH; Wenting GJ; Man in 't Veld AJ; Derkx FH
    Ned Tijdschr Geneeskd; 1980 Nov; 124(47):1996-2003. PubMed ID: 6255350
    [No Abstract]   [Full Text] [Related]  

  • 22. Hemodynamic effects of captopril in essential hypertension, renovascular hypertension and cardiac failure: correlations with short- and long-term effects on plasma renin.
    Wenting GJ; de Bruyn JH; Man in't Veld AJ; Woittiez AJ; Derkx FH; Schalekamp MA
    Am J Cardiol; 1982 Apr; 49(6):1453-9. PubMed ID: 6803562
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension].
    Posadas C; Sánchez G; Boyer JL; Delmar M; Serrano PA
    Arch Inst Cardiol Mex; 1982; 52(4):295-300. PubMed ID: 6291470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical applications of angiotensin-converting enzyme inhibitors.
    Ferguson RK; Vlasses PH; Rotmensch HH
    Am J Med; 1984 Oct; 77(4):690-8. PubMed ID: 6091446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical improvement and hormonal changes in severe cardiac failure after captopril treatment.
    McGrath BP; Denham IM; Johnston CI
    Aust N Z J Med; 1981 Dec; 11(6):639-44. PubMed ID: 6277291
    [No Abstract]   [Full Text] [Related]  

  • 26. [Antihypertensive, hemodynamic and endocrine effects of Captopril in arterial hypertension].
    Valvo E; Previato G; Oldrizzi L; Corgnati A; Lupo A; Loschiavo C; Tessitore N; Maschio G
    Minerva Nefrol; 1981; 28(2):139-41. PubMed ID: 7027091
    [No Abstract]   [Full Text] [Related]  

  • 27. Captopril (Capoten, E.R. Squibb & Sons).
    Harris C; Smith GH
    Drug Intell Clin Pharm; 1981 Dec; 15(12):932-9. PubMed ID: 7040022
    [No Abstract]   [Full Text] [Related]  

  • 28. Acute effects of captopril on cardiopulmonary hemodynamics and renin-angiotensin-aldosterone and bradykinin profile in hypertension.
    Mookherjee S; Anderson GH; Eich R; Hill N; Smulyan H; Streeten DH; Vardan S; Warner R
    Am Heart J; 1983 Jan; 105(1):106-12. PubMed ID: 6336874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors predicting acute and long-term response to captopril therapy in congestive heart failure.
    Levine TB; Cohn JN
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):169S-174S. PubMed ID: 6753898
    [No Abstract]   [Full Text] [Related]  

  • 30. [Pharmacological effects of captopril].
    Rubin B; Antonaccio J
    Nouv Presse Med; 1981 Apr; 10(19):1531-46. PubMed ID: 6269555
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparative effects of enalapril, enalaprilic acid and captopril in blocking angiotensin I-induced pressor and dipsogenic responses in spontaneously hypertensive rats.
    Gaul SL; Martin GE; Sweet CS
    Clin Exp Hypertens A; 1984; 6(6):1187-206. PubMed ID: 6086183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Captopril (Capoten). A new antihypertensive agent blocking the renin-angiotensin system].
    Rasmussen S; Jensen G; Giese J
    Ugeskr Laeger; 1983 May; 145(22):1695-9. PubMed ID: 6349075
    [No Abstract]   [Full Text] [Related]  

  • 33. The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril).
    Kluger J; Cody RJ; Laragh JH
    Am J Cardiol; 1982 May; 49(7):1667-74. PubMed ID: 7044087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The renin-angiotensin system during converting enzyme inhibition with captopril in patients with severe treatment-resistant hypertension.
    Rasmussen S; Damkjaer Nielsen M; Ibsen H; Leth A; Giese J
    Eur J Clin Invest; 1984 Feb; 14(1):30-6. PubMed ID: 6321195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Angiotensin converting enzyme--captopril].
    Kaneko Y; Shionoiri H; Uneda S; Fujishima S
    Nihon Rinsho; 1979 Oct; 37(10):3492-8. PubMed ID: 392136
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of captopril on arterial and venous pressure, renal function, and humoral factors in severe chronic congestive heart failure.
    Kubo S; Nishioka A; Nishimura H; Kawamura K; Takatsu T
    Clin Pharmacol Ther; 1984 Oct; 36(4):456-63. PubMed ID: 6206977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modification of arterial baroreflexes by captopril in essential hypertension.
    Mancia G; Parati G; Pomidossi G; Grassi G; Bertinieri G; Buccino N; Ferrari A; Gregorini L; Rupoli L; Zanchetti A
    Am J Cardiol; 1982 Apr; 49(6):1415-9. PubMed ID: 6803560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy.
    Heel RC; Brogden RN; Speight TM; Avery GS
    Drugs; 1980 Dec; 20(6):409-52. PubMed ID: 7009133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Captopril].
    Mohr K
    Dtsch Med Wochenschr; 1993 Dec; 118(51-52):1899-900. PubMed ID: 8287781
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical use of an orally acting converting enzyme inhibitor: captopril.
    Brunner HR; Gavras H; Waeber B; Textor SC; Turini GA; Wauters JP
    Hypertension; 1980; 2(4):558-66. PubMed ID: 6995296
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.